Internship in Formulation

InformationIn this position, you will support our team in creating a comprehensive overview of all marketed drug products that contain a biologic. Your work will focus on gathering and structuring information about the formulation composition of marketed biologics, including their dosage form such as liquid or lyophilized products and their respective routes of administration. You will collect details on dosage and clinical use, including preparation steps in hospital settings for i.v. products. In addition, you will help generate insights into primary containers and combination products, for example pre-filled syringes or auto-injectors, used for marketed biologics.Your Responsibilities:Preparation of complete list of marketed biologics up to current dateExtract relevant key information on formulation composition, dosage form, dosage frequency from literature and official documentsFile and reference primary sources in a structured wayScreen resources for available information on primary container used in marketed biologics including combination productsCompilation of all data in a well-organized manner for ease of reading and efficient extractionOther tasks related to the project as directed by supervisorIdeal candidates will have:Undergraduate and graduate students of life sciences (Biochemistry, Biology, Bio-Informatics, or Pharmaceutical Sciences)Possibly knowledge in text-extraction methodsAbility to work independently and reliablyGood communication skills and willingness to work in a teamProficiency in MS OfficeFluent in German and English, both written and spokenWhat we offer:A diverse field of activities in a dynamic team with an inspiring, entrepreneurial atmosphereFlat hierarchies and short decision-making pathsSeveral fun team events throughout the yearA workplace near the city of Zurich, overlooking the lakeAbout usNumab Therapeutics AG is an expanding, Swiss biotech company based in Horgen, canton of Zürich. The company is focused on the discovery and development of innovative, antibody fragment-based therapeutics with a focus on inflammation and immuno-oncology. With our breakthrough antibody-discovery and multi-specifics engineering platform, we engage in proprietary projects as well as collaborative research on behalf of partners in the pharmaceutical industry.